Ranjit Bindra
Vice Chair for Translational Research and Faculty Development, Therapeutic Radiology · Yale-New Haven Hospital
Credentials: · · · ·
History
- Present
Therapeutic Radiology · Yale-New Haven Hospital
- Present
Therapeutic Radiology · Yale-New Haven Hospital
- Present
Pediatrics Central Nervous System Radiotherapy Program Division · Yale-New Haven Hospital
Yale University Graduate School
2003–2007
1994–1998- 1993–1998
Research
Review · Neuro-Oncology · 2020 · 995 citations
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
Nature Genetics · 1997 · 698 citations
Science Translational Medicine · 2017 · Last of 21 authors · Corresponding · 470 citations
- PG
26 papers
12 papers
10 papers · 4 as a resident
- PW
9 papers
8 papers · 5 as a resident
8 papers
7 papers
6 papers
Grants
- 2023–2028
Novel Therapeutics for the Targeted Eradication of DDR-Defective Tumors
National Cancer Institute · R01
PI · $2.6M · Yale University
- 2021–2027
Center of Innovation for Brain Tumor Therapeutics
National Cancer Institute · U19
PI · $7.6M · Mayo Clinic Rochester
- 2022–2027
Targeting Defective DNA Damage Response Pathways in IDH1/2-Mutant AML
National Cancer Institute · R01
Contact PI · $3.3M · Yale University
- 2017–2024
Exploiting Mutant IDH1/2-Induced Homologous Recombination Defects in Cancer
National Cancer Institute · R01
Contact PI · $1.9M · Yale University
Clinical trials
- 2014–2017
TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM
Principal investigator · Completed · Phase 1
Cavion, Inc.
- 2020–2023
BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
Study chair · Completed · Phase 1, Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins